BBBT OTC
Black Bird Biotech, Inc.
1W: +0.0%
1M: +0.0%
3M: +9900.0%
YTD: +0.0%
1Y: +0.0%
3Y: -50.0%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$83K
-21.0% ▼
Gross Profit
-$56K
-385.4% ▼
Operating Income
-$1M
+11.2% ▲
Net Income
-$2M
+8.4% ▲
EPS (Diluted)
$-0.01
+46.2% ▲
EBITDA
-$1M
+15.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $18K | $58K | $104K | $83K |
| YoY Growth | +0.0% | +0.0% | +224.1% | +81.3% | -21.0% |
| Cost of Revenue | $0 | $18K | $28K | $85K | $138K |
| Gross Profit | $0 | -$31 | $29K | $20K | -$56K |
| Gross Margin | — | -0.2% | 51.0% | 18.8% | -67.7% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $84K | $80K | $680K | $1M | $1M |
| Operating Expenses | $84K | $80K | $714K | $1M | $1M |
| Operating Income | -$84K | -$80K | -$685K | -$1M | -$1M |
| Operating Margin | — | -451.9% | -1188.8% | -1389.2% | -1560.4% |
| Interest Expense | $38K | $42K | $6K | $285K | $371K |
| Income Before Tax | -$121K | -$122K | -$690K | -$2M | -$2M |
| Tax Expense | $0 | $42K | $0 | $0 | $0 |
| Net Income | -$121K | -$164K | -$692K | -$2M | -$2M |
| Net Margin | — | -920.8% | -1200.6% | -1734.0% | -2009.1% |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.01 | $-0.01 | $-0.01 |
| EBITDA | -$84K | -$146K | -$684K | -$1M | -$1M |
| Shares Outstanding | 86M | 120M | 120M | 194M | 331M |